supplies of erythrocyte immuno-haematology reagents for manual use on tubes or plates and other solutions for EFS laboratories (including the French overseas departments)

Realization 1 (Psl Prep) Anti-A plaque, Anti-B plaque, Anti-Ab plaque reagents

réactifs Anti-Fy1 (Anti-Fya/Upr)

Lot 11 A Production of 1 Anti-Mns3 (Anti-S), Anti-Mns4 (Anti-S) reagents, Monoclonal control.
Lot 11 B Production of 1 anti-Mns3 (anti-S), anti-Mns4 (anti-S) reagents, regulatory control

Realization 2 (Ihe) Anti-Mns3 (Anti-S), Anti-Mns4 (Anti-S) reagents, regulatory control

Lot 13 A Realization 1 (Ihe) Anti-Mns1 (Anti-M), Anti-Mns2 (Anti-N), Monoclonal Control Reagents
Lot 13 B Realization 1 (Ihe) Anti-Mns1 (Anti-M), Anti-Mns2 (Anti-N) reagents, regulatory control

Realization 2 (Ihe) Anti-Mns1 (Anti-M), Anti-Mns2 (Anti-N) Reagents, Regulatory Witness

Lot 15 A Realization 1 (Ihe) Anti-Le1 (Anti-Lea), Anti-Le2 (Anti-), Monoclonal Control.
Lot 15 B Realization 1 (Ihe) Anti-Le1 (Anti-Lea), Anti-Le2 (Anti-), regulatory control

Realization 2 (Ihe) Anti-Le1 (Anti-Lea), Anti-Le2 (Anti-), Control reagents

Lot 17 A Realization 1 (Ihe) Anti-P1 Reagents, Monoclonal Control.
Lot 17 A Realization 1 (Ihe) Anti-P1 Reagents, Regulatory Control.

Realization 2 (Ihe) Anti-P1 Reagents, Control

Lot 19 A Realization 1 (Ihe) Anti-Rh8 (Anti-Cw) Reagents, Monoclonal Control.
Lot 19 B Realization 1 (Ihe) Anti-Rh8 (Anti-CW) Reagents, Regulatory Control

1 (Ihe) Anti-A, Anti-B, Anti-Ab, Anti-Rh1, Anti-Rh2, Anti-Rh3, Anti-Rh4, Anti-Rh5, Anti-Kel1 Reagents, Control

Realization 2 (Ihe) Anti-Rh8 (Anti-Cw) Reagents, Control

Realization 1 (Ihe) Anti-Lu1 (Anti-Lua), Anti-Lu2 (Anti-Lub), Control Reagents

Realization 2 (Ihe) Anti-Lu1 (Anti-Lua), Anti-Lu2 (Anti-Lub), Control Reagents

Lot 23 A Realization 1 (Ihe) Anti-Kel2 reagents (Anti-Kell Cellano), Monoclonal control.
Lot 23 B Realization 1 (Ihe) Anti-Kel2 reagents (Anti-Kell Cellano), regulatory control

Realization 2 (Ihe) Anti-Kel2 Reagents (Anti-Kell Cellano), Control

Realization 1 (Ihe) Anti-Kel3 (Anti-Kpa), Anti-Kel4 (Anti-Kpb) Reagents, Control

Realization 2 (Ihe) Anti-Kel3 (Anti-Kpa), Anti-Kel4 (Anti-Kpb) Reagents, Control

anti-Igg +C3d

anti-Igg

anti-C3d

Realization 2 (Ihe) Anti-A, Anti-B, Anti-Ab, Anti-Rh1, Anti-Rh2, Anti-Rh3, Anti-Rh4, Anti-Rh5, Anti-Kel1, Control Reagents

anti-Iga

Direct Elution Enclosure

Low Ionic Force Medium

Liquid Papain 1 TPS Ready to Use

Realization 1 (Ihe) Anti-A1, Anti-H Reagents

2 (Ihe) reagents Anti-A1, Anti-H

Lot 6 A: Realization 1 (Ihe) Anti-Jk1 (Anti-Jka), Anti-Jk2 (Anti-Jkb) reagents, Monoclonal control.
Lot 6 B: Implementation 1 (Ihe) Anti-JK1 (Anti-JKA), Anti-JK2 (Anti-JKB) reagents, regulatory control

Realization 2 (Ihe) Anti-Jk1 (Anti-Jka), Anti-Jk2 (Anti-Jkb) Reagents, Regulatory Witness

Lot 8 A Realization 1 Anti-Fy1 (Anti-Fya) - anti-Fy2 (Anti-Fyb) - Monoclonal control
Lot 8 B Realization 1 Anti-Fy1 (Anti-Fya) - Anti-Fy2 (Anti-Fyb) - Regulatory Witness

Realization 2 (Ihe) Anti-Fy1 (Anti-Fya), Anti-Fy2 (Anti-Fyb) Reagents, Regulatory Witness